Common Contracts
1 similar Study Agreement contracts
CLINICAL STUDY AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ PROTOCOL: ISIS 678354-CS6 SITE: 3503 PROTOKOL: ISIS 678354-CS6PRACOVIŠTĚ: 3503 IONIS PHARMACEUTICALS, INC.22-JUNE-2023 VERSION: VERSION #1COUNTRY: CZECH REPUBLIC IONIS PHARMACEUTICALS,...Study Agreement • July 27th, 2024
CLINICAL STUDY AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ This clinical study agreement (“Agreement”), effective as of the day of publication in the Contracts Registry (the “Effective Date”), is entered into by and between Medpace Clinical Research, LLC., with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 and VAT No: 81-4138570 , represented by , Senior Associate Director, ("Medpace”), and Fakultní nemocnice v Motole, a clinical research site with its principal office and place of business at V Úvalu 84, 150 06, Praha 5, Czech Republic and ID No: 00064203, represented by:, by delegation,a health care provider("Institution”). Medpace and Institution are each a Party and collectively (the “Parties”).WHEREAS, Ionis Pharmaceuticals, Inc, with its principal office at 2855 Gazelle Court, Carlsbad, CA 92010, United States (“Sponsor”) is sponsoring a clinical study on the compound Olezarsen (the “Study Drug”), in accordance with Protocol No. ISI
